Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 26, 2023 (Week 34)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 13,867 34,834 936,927 1,117,165
New England 201 1,650 24,318 34,456
Connecticut - 430 1,155 8,098
Maine 46 74 1,924 2,105
Massachusetts - 709 15,463 18,487
New Hampshire 45 82 1,776 1,911
Rhode Island 110 694 3,169 3,029
Vermont - 37 831 826
Middle Atlantic 2,007 4,218 122,590 125,714
New Jersey 180 788 21,631 21,732
New York (excluding New York City) 903 1,032 27,048 25,857
New York City - 1,457 38,864 42,030
Pennsylvania 924 1,233 35,047 36,095
East North Central 1,792 5,759 123,149 186,175
Illinois 114 1,811 32,164 46,741
Indiana 242 837 18,334 22,142
Michigan 305 975 21,152 27,929
Ohio 748 2,294 35,195 72,247
Wisconsin 383 562 16,304 17,116
West North Central 989 2,153 60,351 66,688
Iowa 177 334 8,847 9,681
Kansas 71 325 6,034 9,281
Minnesota 116 497 13,924 14,562
Missouri 457 745 20,726 21,079
Nebraska 167 241 5,956 6,372
North Dakota - 92 1,765 2,331
South Dakota 1 125 3,099 3,382
South Atlantic 3,209 7,248 213,178 222,731
Delaware - 210 3,567 3,357
District of Columbia - 191 4,165 5,319
Florida 1,903 2,786 73,971 69,586
Georgia - 1,597 42,665 48,137
Maryland U NC U U
North Carolina - 1,443 36,930 42,731
South Carolina 621 766 21,816 23,752
Virginia 660 976 27,311 26,876
West Virginia 25 104 2,753 2,973
East South Central 1,167 2,450 64,054 73,032
Alabama 696 972 22,458 20,175
Kentucky 366 555 10,739 11,839
Mississippi 105 483 11,125 15,565
Tennessee - 1,094 19,732 25,453
West South Central 590 5,323 111,676 166,523
Arkansas 151 804 10,716 23,652
Louisiana 439 794 23,190 24,212
Oklahoma - 451 6,759 13,581
Texas - 3,399 71,011 105,078
Mountain 925 2,523 68,067 77,176
Arizona - 918 25,304 27,106
Colorado 396 778 17,041 17,091
Idaho 35 155 3,690 3,760
Montana 47 100 1,983 2,732
Nevada 244 367 6,190 10,628
New Mexico 20 257 5,594 7,372
Utah 159 253 7,214 7,348
Wyoming 24 53 1,051 1,139
Pacific 2,987 5,049 149,544 164,670
Alaska 48 121 2,646 3,560
California 2,156 4,112 123,864 127,781
Hawaii - 142 - 3,605
Oregon 321 383 9,919 10,323
Washington 462 590 13,115 19,401
U.S. Territories - 124 1,138 3,053
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 124 1,138 3,053
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 7 39 91
Total 13,867 34,934 938,104 1,120,309
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.